MaryamFouladiMD

Pediatric Neuro-Oncology

Co-Executive Director of Neuro-Oncology

Dr. Fouladi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
700 Childrens Dr
Columbus, OH 43205
Phone+1 614-722-2000

Fax+1 614-722-3369

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma Start of enrollment: 2022 Dec 16
Recruiting
Phase 2
Roles: Contact, Principal Investigator
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma Start of enrollment: 2023 Apr 10
Recruiting
Phase 2
Roles: Principal Investigator, Contact
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion Start of enrollment: 2021 Apr 08
Recruiting
Early Phase 1
Roles: Contact, Study Chair, Principal Investigator
Study of Ribociclib and Everolimus in HGG and DIPG Start of enrollment: 2024 Jun 28
Not yet recruiting
Phase 2
Roles: Principal Investigator, Contact
Targeted Pediatric High-Grade Glioma Therapy Start of enrollment: 2024 Jun 28
Not yet recruiting
Roles: Contact, Study Chair
Study of Olutasidenib and Temozolomide in HGG Start of enrollment: 2024 Jun 01
Not yet recruiting
Phase 2
Roles: Contact
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion Start of enrollment: 2024 Sep 01
Not yet recruiting
Early Phase 1
Roles: Contact, Principal Investigator
Join now to see all

PubMed